What does Animab do?
AnimAb specializes in developing innovative therapeutic antibodies for the treatment of various diseases. The company focuses on harnessing advanced biotechnology to create targeted therapies that address unmet medical needs. With a commitment to improving patient outcomes, AnimAb is at the forefront of antibody research and development.
Juridical situation
Company number
Founding date
EUID number
Type of enterprise
Location
Juridical form
- Sectors
- Forestry companies
- Signals
-
Reporting lossesReporting losses € -5.30M
The company reported a loss in the latest financial year.
Negative cashflowNegative cashflow € -345KOperating cash flow was negative in the latest financial year.
Negative EBITDANegative EBITDA € -541KEBITDA is negative: operating activities are loss-making.
Strong equityStrong equity € 2.76MStrong equity provides a buffer against setbacks.
Low riskLow risk 79.6%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 3.35A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Healthy social debtHealthy social debt 14.3%Social debts stay manageable relative to personnel costs.
|
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
€
29K
|
€
634K
|
€
384K
|
€
503K
|
|
|
€
-541K
|
€
171K
|
€
29K
|
€
200K
|
|
|
€
-5.30M
|
€
-3.81M
|
€
-2.62M
|
€
-1.63M
|
|
|
€
2.76M
|
€
4.06M
|
€
3.68M
|
€
6.30M
|
|
|
79.56%
|
88.47%
|
89.23%
|
94.48%
|
|
|
€
709K
|
€
529K
|
€
444K
|
€
368K
|
|
|
€
1.83M
|
€
3.44M
|
€
3.23M
|
€
5.43M
|
|
|
5.80
|
6.00
|
4.00
|
5.00
|
Publications 9
All publications- Statuten (Vertaling, Cordinatie, Overige Wijzigingen, ) - Kapitaal - Aandelen - Ontslagen - Benoemingen 31/05/2024
- Ontslagen - Benoemingen 30/10/2023
- Statuten (Vertaling, Cordinatie, Overige Wijzigingen, ) - Kapitaal - Aandelen - Ontslagen - Benoemingen 07/11/2022
- Maatschappelijke Zetel - Ontslagen - Benoemingen 17/06/2022
- Ontslagen - Benoemingen 21/04/2022
Frequently asked questions
Answers to the most common questions about Animab, based on official government data and the filed annual accounts.
What is the VAT number of Animab?
The VAT number of Animab is BE0747.674.614.
How many employees work at Animab?
In 2025, Animab employed 5.80 full-time equivalents (FTE).
When was Animab established?
Animab was founded in 27-05-2020.
What is the official address of Animab?
The official address of Animab is Technologiepark-Zwijnaarde 94 Gent 9052.
What is the legal form of Animab?
The juridical form of Animab is Private limited company (BV/SRL).
What is the legal situation of Animab?
The legal situation of Animab is Normal situation.
What is the annual revenue of Animab?
The annual revenue of Animab is €0.
What does Animab do?
AnimAb specializes in developing innovative therapeutic antibodies for the treatment of various diseases. The company focuses on harnessing advanced biotechnology to create targeted therapies that address unmet medical needs. With a commitment to improving patient outcomes, AnimAb is at the forefront of antibody research and development.
Where can I find Animab?
Animab is located at Technologiepark-Zwijnaarde 94 Gent 9052 in Gent (9052).
Is Animab a reliable company?
Animab is a registered Rechtspersoon with company number 0747.674.614 and can be verified through the official CBE database.
What is the credit limit of Animab?
The estimated credit limit of Animab is €134,544.
Is Animab still active?
Animab currently has the status "Normal situation" and is actief.